COMP <GO>
LQDT vs AHG // REVENUE GROWTH (YOY)
Liquidity Services Inc. (NASDAQ) VS. Akso Health Group ADS (NASDAQ) • 15-METRIC TALLY: LQDT 8
— AHG 0
▲ REVENUE GROWTH (YOY) LEADER: LQDT
LAST: $45.29 (+3.32%) • MKT CAP: $1.42B
revenue-growth
31.20%
LAST: $1.33 (+2.31%) • MKT CAP: $1.14B
revenue-growth
-6.40%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LQDT VS. AHG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LQDT | AHG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 43.80% | -0.10% | +43.90 | LQDT | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 12.90% | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | 34.0x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 4.15% | -1.12% | +5.27 | LQDT | /fcf-yield <GO> |
| Operating Margin | 7.40% | -60.00% | +67.40 | LQDT | /operating-margins <GO> |
| Net Profit Margin | 5.90% | -60.00% | +65.90 | LQDT | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 31.20% | -6.40% | +37.60 | LQDT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 7.56 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 2/9 | +6.00 | LQDT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 59.3 | 57.6 | +1.70 | LQDT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 42.4x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.42B | $1.14B | $279.6M | LQDT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LQDT REV | AHG REV | LQDT GROSS % | AHG GROSS % | LQDT FCF | AHG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $476.7M | $13.8M | 43.8% | -0.1% | $59.0M | -$12.8M |
| FY 2024 | $363.3M | $14.8M | 51.0% | -1.9% | $61.3M | $1.0M |
| FY 2023 | $314.5M | $2.4M | — | — | $47.0M | $1.4M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LQDT // BETA —
AHG // BETA —